RecruitingNot ApplicableNCT06930677

Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

A Prospective, Single-arm, Multinational, Multi-center, Clinical Study to Evaluate the Performance and Safety of Musculoskeletal Embolization Using NBGM200 in Patients With Knee Degenerative Osteoarthritis

Sponsor

Next Biomedical Co., Ltd.

Enrollment

72 participants

Start Date

Apr 17, 2025

Study Type

INTERVENTIONAL

Conditions

Knee Osteoarthritis (Knee OA)

Summary

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called embolization therapy for people with knee osteoarthritis (knee oa). The study is currently recruiting participants at 3 locations. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEembolization therapy

MSK embolization

Locations(3)

University Hospital Ghent

Ghent, Belgium

Uz Leuven

Leuven, Belgium

Elisabeth-Tweesteden Hospital

Tilburg, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06930677

Related Trials

Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis

NCT067814631 location

Analysis of the Loss of Muscle Force, Power and Motor Control to Predict the Risk of Falls in Patients With Knee OA

NCT066116181 location